secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2023-04-11T23:59:59+00:00
Accession:  0001213900-23-028851
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Karin Eastham not standing for re-election at Nektar's 2023 annual meeting
--------------------------------------------------------------------------------

- Karin Eastham informed Board she will not stand for re-election, completing term at 2023 annual meeting.
- Departure is not due to any disagreement with the company on operations, policies, or practices.
- Eastham served approximately five years as a director; no replacement announced.
- Company thanks Eastham for her service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390023028851/0001213900-23-028851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390023028851/ea176784-8k_nektartherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-028851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer